表 題 |
著者名 |
誌
名 |
Predictives regarding outcome after transurethral resection for prostatic adenoma associated with detrusor underactivity. |
Seki N, Kai N, Seguchi H, Takei M, Yamaguchi A, Naito S: |
Urology 67 (2): 306-310, 2006 |
Expression and cellular localization of dbpC/Contrin in germ cell tumor cell lines. |
Yoshida T, Izumi H, Uchiumi T, Sasaguri Y, Tanimoto A,
Matsumoto T, Naito S, Kohno K: |
Biochim Biophys Acta 1759 (1-2): 80-88, 2006 |
Clinical outcomesand learning curve of a laparoscopic adrenalectomy in 103 consecutive cases at a single institute. |
Eto M, Harano M, Koga H,
Tanaka M, Naito S: |
Int J Urol 13 (6): 671-676, 2006 |
Histopathological approach to prostatic contour alterations with the concept of left-right asymmetry. |
Kiyoshima K, Oda Y, Tamiya S,
Hori Y, Yamada T, Naito S, Tsuneyoshi M: |
Pathol Int 56 (7): 390-396, 2006 |
Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan. |
Yokomizo A, Murai M, Baba S, Ogawa O, Tsukamoto T,
Niwakawa M, Tobisu K, Kinukawa N, Naito S: |
BJU Int 98 (3): 549-553, 2006 |
Expression and function of Noxo1γ, an alternative splicing form of the NADPH oxidase organizer 1. |
Takaya R, Taura M,
Yamasaki T, Naito S, Sumimoto H: |
FFBS J 273 : 3663-3677, 2006 |
Analysis of prognostic factors regarding the outcome after a transurethral resection for symptomatic benign prostatic enlargement. |
Seki N, Takei M, Yamaguchi A,
Naito S: |
Neurourol Urodyn 25 (5): 428-432, 2006 |
NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel. |
Negishi T, Koizumi F, Uchino H, Kuroda J, Kawaguchi T, Naito S, Matsumura Y: |
Br J Cancer 95 (5): 601-606, 2006 |
Collecting duct (Bellini duct) renal cell carcinoma: A nationwide survey in Japan. |
Tokuda N, Naito S, Matsuzaki O, Nagashima Y, Ozono S, Igarashi T: |
J Urol 176 (1): 40-43, 2006 |
Sustained prophylactic effect of intravesical bacille calmette-guerin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study. |
Hinotsu S, Akaza H, Isaka S, Kanetake H, Kubota Y, Kuroda M, Sinohara N, Shinka T, Tachibana M, Naito S, Hirao Y, The BCG Tokyo 172 Strain Study Group: |
Urology 67 (3): 545-549, 2006 |
In vivo growth of transitional and renal cell carcinoma cell lines can be suppressed by the adenovirus-mediated expression of a soluble form of vascular endothelial growth factor receptor. |
Ichikura H, Eto M, Ueno H,
Harada M, Takayama K, Tokuda N, Tatsugami K, Naito S: |
Oncol Rep 15 (5): 1333-1337, 2006 |
The endoscopic surgical skill qualification system in urological laparoscopy: a novel system in Japan. |
Matsuda T, Ono Y, Terachi T,
Naito S, Baba S, Miki T,
Hirao Y, Okuyama A: |
J Urol 176 (5): 2168-2172, 2006 |
Bicalutamide 80mg combined with a luteinizing hormone-releasing hormone agonist (LHRH-A) versus LHRH-A monotherapy in advanced prostate cancer: findings from a phase III randmized, double-blind, multicenter trial in Japanese patients |
Usami M, Akaza H, Arai Y,
Hirano Y, Kagawa S,Kanetake H, Naito S, Sumiyoshi Y, Takimoto Y, Terai A, Yoshida H, Ohashi Y |
Prostate Cancer Prostatic Dis Jan 2: 1-8, 2006 |
The case for androgen deprivation as primary therapy for early stage diseases: results from J-CaP and CaPSURETM. |
Akaza H, Hinotsu S, Usami M, Ogawa O, Kagawa S, Kitamura T, Tsukamoto T, Naito S, Hirao Y, Murai M, Yamanaka H, Namiki M: |
J Urol 176 (6 pt 2): S47-S49, 2006 |
A questionnaire survey of patient preparation and techniques for prostate biopsy among urologists in the Kyushu and Okinawa regions of Japan. |
Noguchi M, Matsuoka K, Koga H, Kanetake H, Nakagawa M, Naito S: |
Int J Clin Oncol 11 (5): 390-395, 2006 |
A low-dose combination therapy of interleukin-2 and interferon-α is effective for lung metastasis of renal cell carcinoma: a multicenter open study. |
Akaza H, Tsukamoto T, Onishi T, Miki T, Kinouchi T, Naito S: |
Int J Clin Oncol 11 (6): 434-440, 2006 |
Low pre-radiotherapy prostate-specific antigen level is a significant predictor of treatment success for postoperative radiotherapy in patients with prostate cancer. |
Sasaki T, Nakamura K, Shioyama Y, Ohga S, Toba T, Urashima Y, Yoshitake T, Terashima H,
Koga H, Naito S, Noma H,
Komatsu K, Yamaguchi A,
Hiratsuka Y, Hirano T, Hanada K, Abe M, Fujisawa Y, Honda H: |
Anticancer Res 26 (3B): 2367-2374, 2006 |
The members of National research Project on Endocrine-Radiation Combination Therapy for Locally Advanced Prostate Cancer: Longitudinal Assessment of Quality of Life in Men Treated with External Beam Radiotherapy Combined with Neoadjuvant and Adjuvant Endocrine Therapy for Locally Advanced Prostate Cancer. |
Koga H, Ito K, Yamanaka H,
Naito S: |
Int J Urol 13 (Suppl 1): A14, 2006 |
Actions of ZD0947, a novel ATP-sensitive K+ channel opener, on membrane currents in human detrusor myocytes. |
ishima M, Tomoda T, Yunoki T, Nakano T, Seki N, Yonemitsu Y, Sueishi K, Naito S, Ito Y,
Teramoto N: |
Br J Pharmacol 149 (5): 542-550, 2006 |
平成16年度福岡市ミニドックおよび市民公開講座における前立腺がん検診. |
古賀寛史、宮崎良春、辻 祐治、角田和之、長谷川淑博、
吉峰一博、舩津雅夫、柳 宗賢、田原春夫、後藤 健、入江慎一郎、内藤誠二、山口秋人: |
福岡市医報 47 (1): 1-8, 2006 |
根治的前立腺摘除術における骨盤内リンパ節転移を予測する術前因子の検討. |
後藤 健、白石泰三、黒岩顕太郎、古賀寛史、野瀬善明、内藤誠二: |
腎泌予防医誌 14 (1): 76-78, 2006 |
膀胱癌診断における尿中Nuclear Matrix Protein 22 (NMP22) の有用性. |
中島信能、古賀寛史、横溝 晃
内藤誠二、山口秋人、上領頼啓、井口厚司: |
西日泌尿 68 (4): 146-151, 2006 |
近位型尿道下裂に対するYoke法の検討. |
山口孝則、鯉川弥須宏、此元竜雄、中村 繁、上村敏雄、長野正史、長田幸夫、内藤誠二: |
日泌尿会誌 97 (5): 730-736, 2006 |
九州沖縄地区における根治的前立腺摘除術と術後補助療法およびPSA failureに関するアンケート調査. |
酒井英樹、金武 洋、藤本直浩、古賀寛史、内藤誠二、入江慎一郎、野口正典、魚住二郎、濱田泰之、三股浩光、蓮井良浩、西山賢龍 |
西日泌尿 68 (7): 320-328, 2006 |
局所進行前立腺癌に対する内分泌放射線併用療法におけるQOLの検討(厚生労働省がん研究助成金「局所進行前立腺がんに対する内分泌療法・放射線療法併用の意義に関する研究(山中班)」平成17年度中間報告) |
古賀寛史、伊藤一人、松岡直樹、塚本泰司、福井 巌、宇佐美道之、原田昌興、大橋靖雄、古武敏彦、垣添忠生、山中英壽、内藤誠二 |
泌尿外 19 (8): 987-992, 2006 |
回腸利用代用膀胱造設術の日常生活QOL・術後合併症・oncological outcome・腎機能推移について−cutaneous diversion症例との比較検討− |
原野正彦、江藤正俊、甲斐信幸、内藤誠二、中村元信、長谷川淑博、山口秋人、加野資典: |
西日泌尿 68 (10): 459-465, 2006 |